← Leaderboards
Matthew D Stachler
University Of California, San Francisco
$2,885,743
Attributed
$2,885,743
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $691.8K · FY2016–25$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,885,743 · 2
By mechanism
R37$1,956,820 · 1
K08$928,923 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California, San Francisco
Same institution · by research overlap
- William A Weiss$31,543,847
- Michael Clark Oldham$7,077,932
- Brian Crompton$6,355,467
- Michael D. Taylor$7,522,868
- John Matthew Inadomi$9,020,701
Others in their field
Top investigators on “Chronic”
- Judith S. Currier · University Of California Los Angeles$245,012,139
- Lawrence Corey · Fred Hutchinson Cancer Center$209,947,290
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$201,828,077
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$173,476,538
- John M Lachin · George Washington University$125,152,883
- David M Nathan · Massachusetts Institute Of Technology$120,438,756
Research focus
ChronicBile RefluxEarly DiagnosisEsophageal AdenocarcinomaBiological MarkersIncidenceClinically SignificantBarrett EsophagusDysplasiaHigh RiskEsophagusMalignant NeoplasmsMalignant Neoplasm Of EsophagusResponseAmericanFundingDiagnosisAneuploidyIntestinesHistologicDisorder RiskAreaDna Sequence AlterationGenomics
Grant awards (11)
Optimization and validation of a biomarker panel for risk stratification in Barrett's esophagus$614,654
R37 · FY2025 · CA · contact PI
Optimization and validation of a biomarker panel for risk stratification in Barrett's esophagus$77,113
R37 · FY2025 · CA · contact PI
Optimization and validation of a biomarker panel for risk stratification in Barrett's esophagus$582,600
R37 · FY2024 · CA · contact PI
Optimization and validation of a biomarker panel for risk stratification in Barrett's esophagus$38,478
R37 · FY2024 · CA · contact PI
Optimization and validation of a biomarker panel for risk stratification in Barrett's esophagus$643,975
R37 · FY2023 · CA · contact PI
Early TP53 Mutations and Genomic Doubling as a Novel Path for Barrett's Esophagus Progression$81,567
K08 · FY2021 · DK · contact PI
Early TP53 Mutations and Genomic Doubling as a Novel Path for Barrett's Esophagus Progression$172,098
K08 · FY2020 · DK · contact PI
Early TP53 Mutations and Genomic Doubling as a Novel Path for Barrett's Esophagus Progression$172,098
K08 · FY2019 · DK · contact PI
Early TP53 Mutations and Genomic Doubling as a Novel Path for Barrett's Esophagus Progression$171,720
K08 · FY2018 · DK · contact PI
Early TP53 Mutations and Genomic Doubling as a Novel Path for Barrett's Esophagus Progression$171,720
K08 · FY2017 · DK · contact PI
Early TP53 Mutations and Genomic Doubling as a Novel Path for Barrett's Esophagus Progression$159,720
K08 · FY2016 · DK · contact PI